Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia

Last updated: February 1, 2019
Sponsor: University Hospital, Clermont-Ferrand
Overall Status: Active - Recruiting

Phase

N/A

Condition

Psychosis

Tourette's Syndrome

Schizotypal Personality Disorder (Spd)

Treatment

N/A

Clinical Study ID

NCT03471013
CHU-384
2017-A02271-52
  • Ages > 18
  • All Genders

Study Summary

Only one third of patients with schizophrenia are observant to their treatment knowing that the lack of adherence to treatment is one of the most important predictors of relapse.

Recent work shows that the erroneous or negative beliefs of patients with schizophrenia regarding antipsychotic treatment are associated with poor compliance.

The hypothesis is that negative beliefs about the antipsychotic treatment of caregivers of patients with schizophrenia may be associated with a higher risk of poor compliance compared to caregivers with positive beliefs about treatment.

The primary purpose is to explore the correlation between caregiver beliefs about treatment and patient compliance, taking into account the level of caregiver-patient link.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient over 18 years old

  • With a diagnosis of schizophrenia according to DSM-5 criteria

  • Accompanied by his main caregiver, who will be able to complete the questionnairesafter having signed the information form.

  • Treated with one or more antipsychotics.

  • Able to complete the questionnaires related to the protocol

  • Having agreed to sign the information form.

Exclusion

Exclusion Criteria:

  • Not understanding French, unable to answer questions linguistically

  • Presenting an organic pathology and / or cognitive deterioration likely to hinder agood understanding of the interview

  • Having already participated in the study

  • presenting disorders related to the use of substances of severe intensity (such asacute intoxication, withdrawal syndrome or any state of delirium)

Study Design

Total Participants: 150
Study Start date:
March 20, 2018
Estimated Completion Date:
March 30, 2019

Study Description

Non-interventional cross-sectional exploratory study with a single visit for patients with schizophrenia and their caregivers, who agreed to participate in the protocol.

Connect with a study center

  • Chu Clermont-Ferrand

    Clermont-Ferrand, 63003
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.